Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 223

The DOI matches its Crossref record.

Hepatitis B virus–induced lipid alterations contribute to natural killer T cell–dependent protective immunity

Open access
Zeissig, Sebastian, Murata, Kazumoto, Sweet, Lindsay, Publicover, Jean, Hu, Zongyi, Kaser, Arthur, Bosse, Esther, Iqbal, Jahangir, Hussain, M Mahmood, Balschun, Katharina, Röcken, Christoph, Arlt, Alexander, Günther, Rainer, Hampe, Jochen, Schreiber, Stefan, Baron, Jody L, Moody, D Branch, Liang, T Jake, Blumberg, Richard S · 2012 · Nature Medicine

Abstract

In most adult humans, hepatitis B is a self-limiting disease leading to life-long protective immunity, which is the consequence of a robust adaptive immune response occurring weeks after hepatitis B virus (HBV) infection. Notably, HBV-specific T cells can be detected shortly after infection, but the mechanisms underlying this early immune priming and its consequences for subsequent control of viral replication are poorly understood. Using primary human and mouse hepatocytes and mouse models of transgenic and adenoviral HBV expression, we show that HBV-expressing hepatocytes produce endoplasmic reticulum (ER)-associated endogenous antigenic lipids including lysophospholipids that are generated by HBV-induced secretory phospholipases and that lead to activation of natural killer T (NKT) cells. The absence of NKT cells or CD1d or a defect in ER-associated transfer of lipids onto CD1d results in diminished HBV-specific T and B cell responses and delayed viral control in mice. NKT cells may therefore contribute to control of HBV infection through sensing of HBV-induced modified self-lipids.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nm.2811

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 55

  1. Thimme, R. et al. CD8+ T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J. Virol. 77, 68–76 (2003). · DOI · Paper page
  2. Yeo, W. et al. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J. Clin. Oncol. 27, 605–611 (2009). · DOI · Paper page
  3. Esteve, M. et al. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis. Gut 53, 1363–1365 (2004). · DOI · Paper page
  4. Calabrese, L.H., Zein, N.N. & Vassilopoulos, D. Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies. Ann. Rheum. Dis. 65, 983–989 (2006). · doi:10.1136/ard.2005.043257
  5. Thio, C.L. et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360, 1921–1926 (2002). · DOI · Paper page
  6. Guidotti, L.G. & Chisari, F.V. Immunobiology and pathogenesis of viral hepatitis. Annu. Rev. Pathol. 1, 23–61 (2006). · DOI · Paper page
  7. Bendelac, A., Savage, P.B. & Teyton, L. The biology of NKT cells. Annu. Rev. Immunol. 25, 297–336 (2007). · DOI · Paper page
  8. Tupin, E., Kinjo, Y. & Kronenberg, M. The unique role of natural killer T cells in the response to microorganisms. Nat. Rev. Microbiol. 5, 405–417 (2007). · DOI · Paper page
  9. Wieland, S., Thimme, R., Purcell, R.H. & Chisari, F.V. Genomic analysis of the host response to hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 101, 6669–6674 (2004). · DOI · Paper page
  10. Fisicaro, P. et al. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut 58, 974–982 (2009). · DOI · Paper page
  11. Webster, G.J. et al. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 32, 1117–1124 (2000). · DOI · Paper page
  12. Guy, C.S., Mulrooney-Cousins, P.M., Churchill, N.D. & Michalak, T.I. Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus. J. Virol. 82, 8579–8591 (2008). · DOI
  13. Kakimi, K., Guidotti, L.G., Koezuka, Y. & Chisari, F.V. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192, 921–930 (2000). · DOI · Paper page
  14. Isogawa, M., Kakimi, K., Kamamoto, H., Protzer, U. & Chisari, F.V. Differential dynamics of the peripheral and intrahepatic cytotoxic T lymphocyte response to hepatitis B surface antigen. Virology 333, 293–300 (2005). · DOI
  15. Sprinzl, M.F., Oberwinkler, H., Schaller, H. & Protzer, U. Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier. J. Virol. 75, 5108–5118 (2001). · DOI
  16. von Freyend, M.J. et al. Sequential control of hepatitis B virus in a mouse model of acute, self-resolving hepatitis B. J. Viral Hepat. 18, 216–226 (2011). · DOI
  17. Guidotti, L.G. et al. Viral clearance without destruction of infected cells during acute HBV infection. Science 284, 825–829 (1999). · DOI · Paper page
  18. Publicover, J. et al. IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B. J. Clin. Invest. 121, 1154–1162 (2011). · DOI
  19. Baron, J.L. et al. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 16, 583–594 (2002). · DOI · Paper page
  20. Vilarinho, S., Ogasawara, K., Nishimura, S., Lanier, L.L. & Baron, J.L. Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus. Proc. Natl. Acad. Sci. USA 104, 18187–18192 (2007). · DOI
  21. Brozovic, S. et al. CD1d function is regulated by microsomal triglyceride transfer protein. Nat. Med. 10, 535–539 (2004). · DOI · Paper page
  22. Dougan, S.K., Rava, P., Hussain, M.M. & Blumberg, R.S. MTP regulated by an alternate promoter is essential for NKT cell development. J. Exp. Med. 204, 533–545 (2007). · doi:10.1084/jem.20062006
  23. Dougan, S.K. et al. Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells. J. Exp. Med. 202, 529–539 (2005). · DOI
  24. Kaser, A. et al. Microsomal triglyceride transfer protein regulates endogenous and exogenous antigen presentation by group 1 CD1 molecules. Eur. J. Immunol. 38, 2351–2359 (2008). · DOI
  25. Zeissig, S. et al. Primary deficiency of microsomal triglyceride transfer protein in human abetalipoproteinemia is associated with loss of CD1 function. J. Clin. Invest. 120, 2889–2899 (2010). · DOI
  26. Khatun, I. et al. Phospholipid transfer activity of microsomal triglyceride transfer protein produces apolipoprotein B and reduces hepatosteatosis while maintaining low plasma lipids in mice. Hepatology 55, 1356–1368 (2012). · DOI
  27. Ganem, D. & Prince, A.M. Hepatitis B virus infection—natural history and clinical consequences. N. Engl. J. Med. 350, 1118–1129 (2004). · DOI · Paper page
  28. Patient, R., Hourioux, C. & Roingeard, P. Morphogenesis of hepatitis B virus and its subviral envelope particles. Cell. Microbiol. 11, 1561–1570 (2009). · DOI
  29. Satoh, O., Umeda, M., Imai, H., Tunoo, H. & Inoue, K. Lipid composition of hepatitis B virus surface antigen particles and the particle-producing human hepatoma cell lines. J. Lipid Res. 31, 1293–1300 (1990). · DOI
  30. Arrenberg, P., Halder, R., Dai, Y., Maricic, I. & Kumar, V. Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid. Proc. Natl. Acad. Sci. USA 107, 10984–10989 (2010). · DOI
  31. Gumperz, J.E. et al. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12, 211–221 (2000). · DOI · Paper page
  32. Cox, D. et al. Determination of cellular lipids bound to human CD1d molecules. PLoS ONE 4, e5325 (2009). · DOI
  33. Fox, L.M. et al. Recognition of lyso-phospholipids by human natural killer T lymphocytes. PLoS Biol. 7, e1000228 (2009). · DOI · Paper page
  34. Ni, Z., Okeley, N.M., Smart, B.P. & Gelb, M.H. Intracellular actions of group IIA secreted phospholipase A2 and group IVA cytosolic phospholipase A2 contribute to arachidonic acid release and prostaglandin production in rat gastric mucosal cells and transfected human embryonic kidney cells. J. Biol. Chem. 281, 16245–16255 (2006). · DOI
  35. Ito, M. et al. Distribution of type V secretory phospholipase A2 expression in human hepatocytes damaged by liver disease. J. Gastroenterol. Hepatol. 19, 1140–1149 (2004). · DOI
  36. Masuda, S., Murakami, M., Ishikawa, Y., Ishii, T. & Kudo, I. Diverse cellular localizations of secretory phospholipase A2 enzymes in several human tissues. Biochim. Biophys. Acta 1736, 200–210 (2005). · DOI
  37. Kuwata, H., Yamamoto, S., Takekura, A., Murakami, M. & Kudo, I. Group IIA secretory phospholipase A2 is a unique 12/15-lipoxygenase–regulated gene in cytokine-stimulated rat fibroblastic 3Y1 cells. Biochim. Biophys. Acta 1686, 15–23 (2004). · DOI
  38. Tischfield, J.A. et al. Low-molecular-weight, calcium-dependent phospholipase A2 genes are linked and map to homologous chromosome regions in mouse and human. Genomics 32, 328–333 (1996). · doi:10.1006/geno.1996.0126
  39. Brigl, M., Bry, L., Kent, S.C., Gumperz, J.E. & Brenner, M.B. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4, 1230–1237 (2003). · DOI · Paper page
  40. Brigl, M. et al. Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection. J. Exp. Med. 208, 1163–1177 (2011). · DOI · Paper page
  41. Nagarajan, N.A. & Kronenberg, M. Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J. Immunol. 178, 2706–2713 (2007). · DOI · Paper page
  42. Fujii, S., Liu, K., Smith, C., Bonito, A.J. & Steinman, R.M. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J. Exp. Med. 199, 1607–1618 (2004). · DOI · Paper page
  43. Fujii, S., Shimizu, K., Smith, C., Bonifaz, L. & Steinman, R.M. Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 198, 267–279 (2003). · DOI · Paper page
  44. Ishak, K. et al. Histological grading and staging of chronic hepatitis. J. Hepatol. 22, 696–699 (1995). · DOI · Paper page
  45. Smiley, S.T., Kaplan, M.H. & Grusby, M.J. Immunoglobulin E production in the absence of interleukin-4–secreting CD1-dependent cells. Science 275, 977–979 (1997). · DOI · Paper page
  46. Cui, J. et al. Requirement for Vα14 NKT cells in IL-12–mediated rejection of tumors. Science 278, 1623–1626 (1997). · DOI · Paper page
  47. Van Kaer, L., Ashton-Rickardt, P.G., Ploegh, H.L. & Tonegawa, S. TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4–8+ T cells. Cell 71, 1205–1214 (1992). · DOI · Paper page
  48. Postic, C. et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell–specific gene knock-outs using Cre recombinase. J. Biol. Chem. 274, 305–315 (1999). · DOI · Paper page
  49. Raabe, M. et al. Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J. Clin. Invest. 103, 1287–1298 (1999). · DOI · Paper page
  50. Mohrs, M., Shinkai, K., Mohrs, K. & Locksley, R.M. Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter. Immunity 15, 303–311 (2001). · DOI · Paper page
  51. Stetson, D.B. et al. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 198, 1069–1076 (2003). · DOI · Paper page
  52. Chisari, F.V. et al. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc. Natl. Acad. Sci. USA 84, 6909–6913 (1987). · DOI · Paper page
  53. Scapa, E.F. et al. Regulation of energy substrate utilization and hepatic insulin sensitivity by phosphatidylcholine transfer protein/StarD2. FASEB J. 22, 2579–2590 (2008). · DOI
  54. Ernster, L., Siekevitz, P. & Palade, G.E. Enzyme-structure relationships in the endoplasmic reticulum of rat liver: a morphological and biochemical study. J. Cell Biol. 15, 541–562 (1962). · DOI · Paper page
  55. Folch, J., Lees, M. & Sloane Stanley, G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497–509 (1957). · DOI · Paper page

Cited by

Metadata

Authors
Zeissig, S., Murata, K., Sweet, L., Publicover, J., Hu, Z., Kaser, A., Bosse, E., Iqbal, J., Hussain, M. M., Balschun, K., Röcken, C., Arlt, A., Günther, R., Hampe, J., Schreiber, S., Baron, J. L., Moody, D. B., Liang, T. J., & Blumberg, R. S.
Venue
Nature Medicine
Published
2012-06-17
Volume
18
Issue
7
Pages
1060-1068
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W1988932163
Cited by
223
References
0
FWCI
18.10
Type
journal article
Language
en
Open access
green
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.